Identification of a Unique cyp51A Mutation in Aspergillus fumigatus from a Patient with Systemic Lupus Erythematosus and Limited Systemic Sclerosis: The First Report of Acquired Azole Resistance in Colombia - Top-Institutions - MDSpire

Identification of a Unique cyp51A Mutation in Aspergillus fumigatus from a Patient with Systemic Lupus Erythematosus and Limited Systemic Sclerosis: The First Report of Acquired Azole Resistance in Colombia

  • By

  • Carlos Morales-Pertuz

  • Miguel Ángel Vanegas

  • Ximena Castañeda-Luquerna

  • Eliana Maldonado

  • Jorge Alberto Carrillo

  • Anghie Katherine López-Valencia

  • Carolina Firacative

  • March 2, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Mycology
    • Epidemiology

  • #2

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Medical Mycology

  • #3

    University of Manchester - Mycology Reference Centre
    University of Manchester - Mycology Reference Centre

    Manchester, UK

    Key Differentiators

    • Medical Mycology
    • Infectious Diseases
    • Microbiology

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Medical Mycology
    • Pulmonology

  • #5

    Fundación Santa Fe de Bogotá
    Fundación Santa Fe de Bogotá

    Bogotá, Colombia

    Key Differentiators

    • Infectious Diseases
    • Medical Mycology
    • Immunology

Original Source(s)

Identification of a Unique cyp51A Mutation in Aspergillus fumigatus from a Patient with Systemic Lupus Erythematosus and Limited Systemic Sclerosis: The First Report of Acquired Azole Resistance in Colombia

  • by Carlos Morales-Pertuz, Miguel Ángel Vanegas, Ximena Castañeda-Luquerna, Eliana Maldonado, Jorge Alberto Carrillo, Anghie Katherine López-Valencia, Carolina Firacative

  • March 2, 2026

Related Content

Childhood-onset systemic lupus erythematosus presenting with growth retardation and delayed puberty: a case report

Neutrophil extracellular traps and pyroptosis: a molecular nexus linking systemic autoimmune diseases to atherosclerosis

Correction: Clinical significance of erythrocyte sedimentation rate-based stratification in a large retrospective SLE cohort